Huma Therapeutics, a prominent global digital health company, has announced a strategic collaboration with Google Cloud’s generative AI (GenAI) to enhance its regulated disease management platform. This partnership aims to revolutionize healthcare delivery by harnessing the power of AI to streamline processes, improve patient care, and support healthcare professionals (HCPs).

One of the primary goals of this collaboration is to reduce administrative tasks within healthcare systems, freeing up valuable time for HCPs to focus on patient-centric care. GenAI, including the specialized medical language model Med-PaLM 2, will automate the generation of clinical summary reports from patient data, enhancing the documentation and triaging processes.

Huma’s platform collects a vast amount of real-world data that contains critical clinical insights, but these insights can sometimes go unnoticed. By combining GenAI with human oversight, the full potential of this data can be harnessed to deliver predictive and personalized care, benefiting both health systems and patients.

Furthermore, GenAI will address the challenge of patient engagement in chronic disease management. The technology will enable streamlined communication between patients and providers, facilitating individually tailored care plans and personalized support, ultimately leading to improved patient outcomes and a better overall experience.

Crucially, Huma intends to implement GenAI applications safely, with a «human in the loop,» ensuring that qualified nurses or clinicians can assess, validate, and adjust AI outputs within appropriate guardrails

Article written by Robert Barrie| Image by Enterprise Talk



Medical Device Network